FIELD: medicine, dermatology. SUBSTANCE: invention relates to the use of CGRP-antagonist in cosmetic, pharmaceutical or dermatological composition, especially for topical using, to treat shingles, prurigos, prurigous toxicodermatosis and severe itches and to the novel compositions based on said. Composition containing CGRP-antagonist has additionally at least one antagonist taken among antagonists of P substance and antagonists of inflammation mediating agent. EFFECT: broadened arsenal of agents of indicated prescription. 21 cl, 6 ex
Authors
Dates
2000-07-20—Published
1996-03-27—Filed